Current therapeutic approaches in the initial stages of AD often focus on enhancing cholinergic function in the brain, such as using Aricept (Donepezil), which inhibits the activity of AChE, thereby increasing ACh levels. This evidence concerns the gene ACHE and Alzheimer disease.